ACET · Adicet Bio, Inc.
$8.20
+0.14 (+1.74%)
At close · Jul 28
Market Cap
$76.66M
Shares
9.35M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Net Income
-$116.8M
+0.3%
FY2025
Diluted EPS
-$16.95
+20.5%
FY2025
Operating Cash Flow
-$95.25M
-3.1%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| $93.8M | $99.13M | $99.32M | $106.04M | $71.25M | $48.94M | $34.33M | $23.69M | $14.72M | $16.84M | |
| $20M | $22.99M | $28.29M | $26.53M | $26.3M | $22.22M | $22.76M | $8.69M | $8.43M | $2.04M | |
| $6.04M | $6.38M | $6.47M | $6.1M | $2.58M | $1.54M | $1.23M | $1.24M | $1.22M | $5000 | |
| $113.8M | $122.11M | $127.62M | $152.04M | $97.54M | $71.16M | $57.09M | $32.38M | $23.15M | $18.88M | |
| — | — | — | — | — | — | — | $85.46M | $39.71M | $18.88M | |
| -$113.8M | -$122.11M | -$127.62M | -$152.04M | -$72.55M | -$61.43M | -$39.19M | -$31.39M | -$14.96M | -$18.88M | |
| $59K | $36K | $4000 | $25K | $80K | $176K | $134K | — | — | — | |
| -$411K | -$430K | -$217K | -$573K | -$919K | -$606K | -$953K | $2.33M | $4.53M | -$14.9M | |
| -$108.83M | -$116.8M | -$117.12M | -$142.66M | -$69.79M | -$62.12M | -$39.49M | -$28.12M | -$9.89M | -$33.78M | |
| $0 | $0 | $0 | $0 | $0 | -$125K | -$2.82M | $19K | -$589K | $0 | |
| -$108.83M | -$116.8M | -$117.12M | -$142.66M | -$69.79M | -$62M | -$36.68M | -$28.14M | -$9.3M | -$33.78M | |
| -$108.83M | -$116.8M | -$117.12M | -$142.66M | -$69.79M | -$62M | -$36.68M | -$28.14M | -$9.3M | -$33.78M | |
| -$108.86M | -$116.72M | -$117.11M | -$142.66M | -$69.79M | -$62.02M | -$36.68M | -$28.1M | -$9.31M | -$33.78M | |
| USD/shares | — | -$16.95 | -$21.33 | -$52.96 | -$27.20 | -$32.00 | — | — | — | — |
| USD/shares | — | -$16.95 | -$21.33 | -$52.96 | -$27.20 | -$32.00 | — | — | — | — |
| shares | — | 6.89M | 5.49M | 2.69M | 2.57M | 1.93M | 457.5K | 134.27K | 128.11K | 35.8K |
| shares | — | 6.89M | 5.49M | 2.69M | 2.57M | 1.93M | 457.5K | 133.69K | 121.69K | 35.8K |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Peer median 4.16×
EV/EBIT
—
Peer median 27.11×
P/E (TTM)
—
Peer median 2.11×
Peer medians compare against the 298 similar-size Biotechnology companies (of 522 listed).